image
Healthcare - Biotechnology - NASDAQ - US
$ 0.33
9.63 %
$ 1.6 M
Market Cap
0.0
P/E
BALANCE SHEET
11.8 M ASSETS
137.08%
16.5 M LIABILITIES
26.75%
-4.71 M EQUITY
41.48%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Panbela Therapeutics, Inc.
image
Current Assets 3.06 M
Cash & Short-Term Investments 2.58 M
Receivables 0
Other Current Assets 482 K
Non-Current Assets 8.74 M
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 8.74 M
Current Liabilities 12.3 M
Accounts Payable 9.94 M
Short-Term Debt 1 M
Other Current Liabilities 1.38 M
Non-Current Liabilities 4.19 M
Long-Term Debt 4.19 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 2.6 1.3 11.9 9.0 2.4 1.4 0.2 0.4 0.9 0.2 58.8 K 0.1 47.9 K
Short Term Investments 0 0 0 0 0 0 0 0 0 499 0 0 18.3 K
Receivables 0 49 K 0.3 0.3 0.4 0.3 0.4 0.3 0.7 0.2 0.4 0.2 0.2
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0.5 0.4 91 K 0.4 0.3 0.1 0.2 0.1 74 K 0.2 318 389 342
Total Current Assets 3.1 1.8 12.3 9.8 3.1 1.8 0.8 0.9 1.7 0.4 0.4 0.3 0.2
PP&E 0 0 0 0 0 0 0 0 0 13 K 19.2 K 15.9 K 9.83 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0.407 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 8.7 3.2 0.6 56 K 51 K 51 K 0 0 76 K 3.03 K 80.2 K 0.3 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 11.8 5.0 12.9 9.8 3.1 1.9 0.8 0.9 1.8 0.4 0.5 0.6 0.3
LIABILITIES
Accounts Payable 9.9 2.9 0.6 0.6 0.6 1.1 1.2 1.2 0.6 0.3 4 K 28.1 K 38.7 K
Short Term Debt 1.0 1.6 0 0 0.1 0.3 1.5 3.3 0.2 0.6 0.6 0.6 0.6
Other Current Liabilities 1.4 3.3 2.0 0.8 1.0 0.2 1.4 1.0 0.5 (0.6) 51.4 K 10.3 K 27.8 K
Total Current Liabilities 12.3 7.8 2.7 1.4 1.8 1.6 4.2 5.5 1.4 0.6 0.7 0.6 0.7
Long Term Debt 4.2 5.2 0 0 0 0 0.3 0 3.0 2.41 K 12.9 K 8.25 K 3.83 K
Deferred Tax Income 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Liabilities 0 0 0 0 0 0 0 0 39 K 0 6.46 K 0 0
Total Liabilities 16.5 13.0 2.7 1.4 1.8 1.6 4.5 5.5 4.5 0.6 0.7 0.7 0.7
EQUITY
Common Stock 0 1 K 13 K 10 K 7 K 5 K 4 K 32 K 30 K 6 5 86 K 86 K
Retained Earnings (125.5) (91.1) (56.2) (46.0) (41.3) (35.1) (29.2) (18.8) (13.7) (14.0) (13.9) (13.7) (13.9)
Other Accumulative Comprehensive Income/Loss 0.7 0.8 0.1 (0.4) 0.3 0.3 (0.2) 76 K 13 K (0.1) 95.7 K 86.9 K 81.3 K
Total Equity (4.7) (8.0) 10.2 8.4 1.4 0.3 (3.7) (4.6) (2.7) (0.2) (0.1) 40.8 K (0.4)
Total Liabilities and Equity 11.8 5.0 12.9 9.8 3.1 1.9 0.8 0.9 1.8 0.4 0.5 0.6 0.3
SHARES OUTSTANDING
Common Shares Outstanding 109 857 488 322 238 3.88 K 2.97 K 2.59 K 1.17 K 120 120 120 120